Pivotal Phase III liver cancer study enrolling in Europe and IsraelRAMAT GAN, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ...

Hepatocellular carcinoma (HCC) represents the most common primary malignancy of the liver and remains a leading cause of ...

El-Khoueiry, MD, discussed nivolumab plus ipilimumab vs lenvatinib/sorafenib in unresectable HCC. Immunotherapy has become a ...

Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.

Joint components contributed substantially to model performance, while distinct components captured phase-specific variations.

An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting ...

Novel early-detection model based on cfDNA methylation and fragmentation features for liver cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include ...

Early detection of hepatocellular carcinoma (HCC) is crucial for improving patient outcomes and offers the best chance for curative treatment, making HCC screening a vital strategy for high-risk ...

A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with ...